VSee Health, Inc. Increase (Decrease) in Accounts Receivable
VSee Health, Inc. (VSEE) reported Increase (Decrease) in Accounts Receivable of $861.91 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-14
- VSee Health, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $355.80K, a 21.38% decline year-over-year.
- VSee Health, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $506.12K, a 98.38% increase year-over-year.
- VSee Health, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $450.57K, a 47.93% decline year-over-year.
- VSee Health, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $675.55K, a 60.59% increase year-over-year.
- VSee Health, Inc. increase (decrease) in accounts receivable for fiscal 2025 was $1.83M, a 67.59% increase from fiscal 2024.
- VSee Health, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $1.09M, a 343.92% increase from fiscal 2023.
- VSee Health, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $246.48K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $355.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $861.91K 10-Q · filed 2026-08-14 | $1.31M derived: sum of 3 quarters · filed 2026-08-14 | $1.99M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $506.12K 10-Q · filed 2026-05-15 | $956.69K derived: sum of 2 quarters · filed 2026-05-15 | $1.63M derived: sum of 3 quarters · filed 2026-05-15 | $2.08M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | $450.57K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.13M derived: sum of 2 quarters · filed 2026-03-31 | $1.58M derived: sum of 3 quarters · filed 2026-08-14 | $1.83M 10-K · filed 2026-03-31 | ||
| 2025-09-30 | $675.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $1.13M derived: sum of 2 quarters · filed 2026-08-14 | $1.38M 10-Q · filed 2025-11-14 | $2.25M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $452.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $707.67K 10-Q · filed 2026-08-14 | $147.26K 10-Q · filed 2025-10-15 | $1.57M derived: sum of 3 quarters · filed 2026-08-14 | $1.99M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $255.13K 10-Q · filed 2026-05-15 | $1.12M derived: sum of 2 quarters · filed 2026-05-15 | $1.54M derived: sum of 3 quarters · filed 2026-05-15 | $1.32M derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | $865.29K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.29M derived: sum of 2 quarters · filed 2026-03-31 | $1.06M derived: sum of 3 quarters · filed 2026-03-31 | $1.09M 10-K · filed 2026-03-31 | ||
| 2024-09-30 | $420.68K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2025-11-14 | $195.79K derived: sum of 2 quarters · filed 2025-11-20 | $228.90K 10-Q · filed 2025-11-14 | $203.90K 10-Q · filed 2024-11-14 | $188.79K derived: sum of 4 quarters · filed 2025-11-20 | |
| 2024-06-30 | -$224.89K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2025-11-20 | -$191.77K 10-Q/A · filed 2025-11-20 | -$216.77K 10-Q · filed 2024-09-23 | -$231.89K derived: sum of 3 quarters · filed 2025-11-20 | -$52.54K derived: sum of 4 quarters · filed 2025-11-20 | |
| 2024-03-31 | $33.12K 10-Q · filed 2025-10-15 | -$7.00K derived: sum of 2 quarters · filed 2025-10-15 | $172.35K derived: sum of 3 quarters · filed 2025-10-15 | |||
| 2023-12-31 | -$40.12K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-29 | $139.23K derived: sum of 2 quarters · filed 2025-08-29 | $246.48K 10-K/A · filed 2025-08-29 | |||
| 2023-09-30 | $179.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $286.60K 10-Q · filed 2024-11-14 | ||||
| 2023-06-30 | $107.25K 10-Q · filed 2024-09-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |